Cercis siliquastrum
Cercis siliquastrum · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cercis siliquastrum, commonly known as the Judas tree, is a deciduous species celebrated for its striking ornamental blooms. While the flowers are its most famous feature, the plant's leaves hold significant biological potential for various applications. Researchers are increasingly focusing on the chemical composition of these leaves to uncover hidden medicinal properties. Through the development of specialized leaf extracts, scientists aim to isolate bioactive compounds for therapeutic use. Consequently, studying these botanical preparations offers a promising pathway for advancing natural pharmacology.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Southern America
- Plant Parts
- Leaf
Classification
Common Names
Cercis siliquastrum is a fascinating species known by a variety of evocative common names across different languages. In Italy, it is affectionately referred to as Albero di Giuda, while in Denmark, it is recognized as Almindelig judastræ. French speakers often identify the tree as Arbre de Judee or Arbre de Judée. Interestingly, it is also sometimes called Arbre de l'amor, adding a romantic dimension to its botanical identity. These diverse names reflect the plant's widespread cultural significance and its enduring charm throughout Europe.
Sources: Catalogue of Life (COL)
Taxonomy
Cercis siliquastrum is a distinctive botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida, marking its place among the true flowering plants. This species is further organized into the order Fabales, a group that shares specific evolutionary traits. As a member of the family Fabaceae, it exhibits the characteristic features common to the legume family. Ultimately, its scientific identity is defined by its placement within the genus Cercis.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Cercis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cercis siliquastrum exhibits a broad geographic range that spans across several distinct regions. Its presence is widely noted throughout Africa, specifically within the diverse landscapes of Macaronesia and Madeira. Within the African continent, the species is well-established across Northern Africa, with significant populations found in Algeria, Morocco, and Tunisia. Beyond these southern territories, the plant also extends its reach into the Asia-Temperate zone. Specifically, it can be found thriving in the North Caucasus region, showcasing its ability to adapt to varied climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cercis siliquastrum is a self-supporting plant characterized by its distinct tree growth form. This species typically reaches a modest stature, with heights ranging from a minimum of 2 m to a maximum of 8 m. Its structural integrity allows it to stand independently within various landscape settings. Consequently, it serves as an ideal ornamental choice for those seeking manageable tree dimensions.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Cercis siliquastrum leaf extracts exhibit strong inhibitory activity against the enzyme 2C-methyl-D-erythritol 4-phosphate synthase (IspC). This enzyme catalyzes the first committed step of the non-mevalonate pathway, which is essential for isoprenoid biosynthesis in certain pathogens. Because this pathway is absent in mammalian cells, targeting IspC with plant-derived compounds presents a promising strategy for anti-infective chemotherapy. The medicinal potential of Cercis siliquastrum was identified through the use of photometric and NMR spectroscopic assays. Consequently, the plant serves as a significant source of natural inhibitors for this specific anti-malarial drug target.
Preparations
Cercis siliquastrum is prepared as leaf extracts to investigate its potential medicinal properties. These specific extracts were utilized in a screening process to identify inhibitors of the 2C-methyl-D-erythritol 4-phosphate synthase enzyme. Through the use of photometric and NMR spectroscopic assays, researchers evaluated the effectiveness of these plant preparations. The study ultimately revealed that the leaf extracts of this species exhibited the strongest inhibitory activity against the target enzyme. Consequently, these preparations serve as a significant focus for developing anti-malarial drug targets.
Parts used
Cercis siliquastrum has been identified as a significant source of potential anti-malarial compounds during recent biochemical screenings. Researchers focused on finding inhibitors for the IspC protein, which is a vital enzyme in the non-mevalonate pathway of protozoa like Plasmodium. To identify these inhibitors, various extracts from Mediterranean plants were tested using specialized photometric and NMR spectroscopic assays. The study revealed that the strongest inhibitory activity was specifically concentrated within the leaf extracts of the species. This discovery highlights the importance of the plant's leaf as a key component for developing new anti-infective chemotherapies.